Treatments:Diabetes
From Proteopedia
(Difference between revisions)
| (12 intermediate revisions not shown.) | |||
| Line 2: | Line 2: | ||
<tr> | <tr> | ||
<td style="width:25%; vertical-align:top;border-width:1px;"> | <td style="width:25%; vertical-align:top;border-width:1px;"> | ||
| - | ===== | + | =====[[Insulin]]===== |
| - | * [[Galvus]] - Generic: Vildagliptin | + | *[[Lantus]] - Generic: [[Insulin glargine]] |
| - | * [[Januvia]] - Generic: Sitagliptin | + | *[[NovoLog]] - Generic: [[Insulin aspart]] |
| - | * [[Onglyza]] - Generic: Saxagliptin | + | *[[Humalog]] - Generic: [[Insulin lispro]] |
| + | =====[[Dipeptidyl peptidase IV]] Inhibitor===== | ||
| + | * [[Galvus]] - Generic: [[Vildagliptin]] | ||
| + | * [[Januvia]] - Generic: [[Sitagliptin]]; see also [[Januvia (sitagliptin)]] | ||
| + | * [[Onglyza]] - Generic: [[Saxagliptin]] | ||
=====[[Peroxisome Proliferator-Activated Receptor]] Agonist===== | =====[[Peroxisome Proliferator-Activated Receptor]] Agonist===== | ||
| - | * [[Actos]] - Generic: Pioglitazone | + | * [[Actos]] - Generic: [[Pioglitazone]] |
| - | * [[Avandia]] - Generic: Rosiglitazone | + | * [[Avandia]] - Generic: [[Rosiglitazone]] |
| + | =====[[Glucagon-like peptide 1 receptor|Glucagon-like peptide-1]] (GLP-1) agonist===== | ||
| + | * [[Victoza]] - Generic: [[Liraglutide]] | ||
| + | * [[Ozempic]] - Generic: [[Semaglutide]] | ||
| + | |||
| + | =====Mechanism is not completely understood===== | ||
| + | *[[Metformin]] - Generic: [[N,N-dimethylbiguanide]] | ||
| + | =====Inhibitors of the sodium glucose co-transporter-2 (SGLT-2)===== | ||
| + | *[[Empagliflozin]] - Generic: Jardiance | ||
| + | *[[Canagliflozin]] | ||
| + | *[[Dapagliflozin]] | ||
| + | |||
</td> | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
Current revision
Insulin
Dipeptidyl peptidase IV Inhibitor
Peroxisome Proliferator-Activated Receptor Agonist
Glucagon-like peptide-1 (GLP-1) agonist
Mechanism is not completely understood
Inhibitors of the sodium glucose co-transporter-2 (SGLT-2)
|
Proteopedia Page Contributors and Editors (what is this?)
Alexander Berchansky, David Canner, Michal Harel, Karsten Theis
